drugset / Trial / NCT02633969

Study of Indomethacin Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age

NCT02633969

Phase 2 Completed 30 enrolled Iroko Pharmaceuticals, LLC
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purposes of this study are to evaluate the safety and tolerability and to model the single-dose pharmacokinetic profile of indomethacin capsules low dose and high dose in children ages 6 to \<17 years experiencing mild to moderate acute postoperative pain.

Timeline

Start
2015-12
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Indomethacin Small molecule

Indications

No indication recorded.